Quality of Life in a Multi-enter Phase II Trial of Neoadjuvant Full Dose Gemcitabine, Oxaliplatin and Radiation in Patients with Resectable or Borderline Resectable Pancreatic Adenocarcinoma Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Serrano Aybar, Pablo
  • Serrano, PE
  • Herman, JM
  • Laheru, DA
  • Wolfgang, C
  • Zalupski, MM
  • Kim, EJ
  • Bekaii-Saab, TS
  • Moore, MJ
  • Dawson, LA
  • Ringash, JG
  • Wei, AC

publication date

  • February 1, 2013